Volume 39 Issue 6
Jun.  2023
Turn off MathJax
Article Contents
Guo QG,Wang S,Yan M,et al.Prospective randomized controlled trial on 2 940 nm fractional erbium laser combined with fractional micro-plasma radiofrequency in the treatment of facial atrophic acne scars[J].Chin J Burns Wounds,2023,39(6):512-517.DOI: 10.3760/cma.j.cn501225-20230116-00018.
Citation: Guo QG,Wang S,Yan M,et al.Prospective randomized controlled trial on 2 940 nm fractional erbium laser combined with fractional micro-plasma radiofrequency in the treatment of facial atrophic acne scars[J].Chin J Burns Wounds,2023,39(6):512-517.DOI: 10.3760/cma.j.cn501225-20230116-00018.

Prospective randomized controlled trial on 2 940 nm fractional erbium laser combined with fractional micro-plasma radiofrequency in the treatment of facial atrophic acne scars

doi: 10.3760/cma.j.cn501225-20230116-00018
Funds:

The Three-year Action Plan of Shanghai Hospital Development Center SHDC2022CRT020

More Information
  •   Objective   To compare the efficacy and safety of 2 940 nm fractional erbium laser combined with fractional micro-plasma radiofrequency (FMR) therapy and 2 940 nm fractional erbium laser in the treatment of atrophic acne scars.   Methods   A prospective randomized controlled research was conducted. A total of 100 atrophic acne scar patients (38 males and 62 females, aged 18-37 years) who were treated in the Scar Laser Clinic of the Department of Plastic and Reconstructive Surgery of Shanghai Ninth People's Hospital of Shanghai Jiao Tong University School of Medicine from March 2018 to March 2021 and conformed to the inclusion criteria were recruited. The patients were randomly divided into erbium laser+FMR group and erbium laser alone group, with 50 cases in each group. The facial acne scars of patients in erbium laser alone group were treated with 2 940 nm fractional erbium laser, while the facial acne scars of patients in erbium laser+FMR group were treated with erbium laser as above, besides, the scars of U and M types were treated with FMR, once every 3 months for a total of 3 times. Before the first treatment and 3 months after each treatment, the Echelle D'Assessment Clinique des Cicatrices D'Acne (ECCA) was used to score the scar. The occurrence of adverse reaction during the treatment process was observed and recorded, and the incidence was calculated. Three months after the last treatment, the 5-level classification method was used to evaluate the satisfaction of patients with the treatment effect, and the satisfaction rate was calculated. Data were statistically analyzed with independent sample t test and chi-square test.   Results   A total of 89 patients completed the study, including 46 patients in erbium laser+FMR group (19 males and 27 females, aged (26±5) years) and 43 patients in erbium laser alone group (15 males and 28 females, aged (27±6) years). The ECCA scores before the first treatment and 3 months after the first treatment of patients were similar between the two groups ( P>0.05). The ECCA scores of patients in erbium laser+FMR group at 3 months after the second and third treatment were 72±23 and 61±18, respectively, which were significantly lower than 85±26 and 76±25 in erbium laser alone group (with t values of -2.45 and -3.26, respectively, P<0.05). During the treatment process, the incidence of adverse reaction of patients in erbium laser+FMR group and erbium laser alone group were 23.91% (11/46) and 16.28% (7/43), respectively, and there was no statistically significant difference between the two groups ( P>0.05). The satisfaction rate of patients in erbium laser+FMR group was 78.26% (36/46) at 3 months after the last treatment, which was significantly higher than 53.49% (23/43) in erbium laser alone group ( χ 2=6.10, P<0.05).   Conclusions   The 2 940 nm fractional erbium laser combined with FMR is superior to 2 940 nm fractional erbium laser alone in the treatment of facial atrophic acne scars, achieving significantly higher efficacy without significantly increasing the incidence of adverse reaction, and patients are more satisfied with the efficacy. It can be used as a recommended therapy in clinical practice.

     

  • loading
  • [1]
    MohsinN,HernandezLE,MartinMR,et al.Acne treatment review and future perspectives[J].Dermatol Ther,2022,35(9):e15719.DOI: 10.1111/dth.15719.
    [2]
    ChungHJ,Al JanahiS,ChoSB,et al.Chemical reconstruction of skin scars (CROSS) method for atrophic scars: a comprehensive review[J].J Cosmet Dermatol,2021,20(1):18-27.DOI: 10.1111/jocd.13556.
    [3]
    ChilickaK,RusztowiczM,SzygułaR,et al.Methods for the improvement of acne scars used in dermatology and cosmetology: a review[J].J Clin Med,2022,11(10):2744.DOI: 10.3390/jcm11102744.
    [4]
    XuY,DengY.Ablative fractional CO2 laser for facial atrophic acne scars[J].Facial Plast Surg,2018,34(2):205-219.DOI: 10.1055/s-0037-1606096.
    [5]
    向芳,于世荣,丁媛.点阵铒激光联合微剥脱模式治疗痤疮瘢痕疗效观察[J].实用皮肤病学杂志,2014,7(2):126-128.DOI: 10.11786/sypfbxzz.1674-1293.20140215.
    [6]
    GuptaV,SharmaVK.Skin typing: Fitzpatrick grading and others[J].Clin Dermatol,2019,37(5):430-436.DOI: 10.1016/j.clindermatol.2019.07.010.
    [7]
    DrenoB,KhammariA,OrainN,et al.ECCA grading scale: an original validated acne scar grading scale for clinical practice in dermatology[J].Dermatology,2007,214(1):46-51.DOI: 10.1159/000096912.
    [8]
    ClaytonRW,GöbelK,NiessenCM,et al.Homeostasis of the sebaceous gland and mechanisms of acne pathogenesis[J].Br J Dermatol,2019,181(4):677-690.DOI: 10.1111/bjd.17981.
    [9]
    Stamu-O'BrienC,JafferanyM,CarniciuS,et al.Psychodermatology of acne: psychological aspects and effects of acne vulgaris[J].J Cosmet Dermatol,2021,20(4):1080-1083.DOI: 10.1111/jocd.13765.
    [10]
    BhargavaS,CunhaPR,LeeJ,et al.Acne scarring management: systematic review and evaluation of the evidence[J].Am J Clin Dermatol,2018,19(4):459-477.DOI: 10.1007/s40257-018-0358-5.
    [11]
    BoenM,JacobC.A review and update of treatment options using the acne scar classification system[J].Dermatol Surg,2019,45(3):411-422.DOI: 10.1097/DSS.0000000000001765.
    [12]
    SalamehF,ShumakerPR,GoodmanGJ,et al.Energy-based devices for the treatment of acne scars: 2022 international consensus recommendations[J].Lasers Surg Med,2022,54(1):10-26.DOI: 10.1002/lsm.23484.
    [13]
    ZhangDD,ZhaoWY,FangQQ,et al.The efficacy of fractional CO2 laser in acne scar treatment: a meta-analysis[J].Dermatol Ther,2021,34(1):e14539.DOI: 10.1111/dth.14539.
    [14]
    PaaschU,ZidaneM,BaronJM,et al.S2k guideline: laser therapy of the skin[J].J Dtsch Dermatol Ges,2022,20(9):1248-1267.DOI: 10.1111/ddg.14879.
    [15]
    ChenL,WangY,JiangL,et al.Comparison of 2940 nm Er: YAG laser treatment in the microlaser peel, fractional ablative laser, or combined modes for the treatment of concave acne scars[J].Medicine (Baltimore),2021,100(28):e26642.DOI: 10.1097/MD.0000000000026642.
    [16]
    LuK,CaiS.Efficacy and safety comparison between 1927 nm thulium laser and 2940 nm Er:YAG laser in the treatment of facial atrophic acne scarring: a prospective, simultaneous spilt-face clinical trial[J].Lasers Med Sci,2022,37(3):2025-2031.DOI: 10.1007/s10103-021-03465-0.
    [17]
    CenkH,SaracG.Effectiveness and safety of 2940-nm multifractional Er: YAG laser on acne scars[J].Dermatol Ther,2020,33(6):e14270.DOI: 10.1111/dth.14270.
    [18]
    XinF,LiuLH,Alexiades-ArmenakasM,et al.Histological and electron microscopic analysis of fractional micro-plasma radio-frequency technology effects[J].J Drugs Dermatol,2013,12(11):1210-1214.
    [19]
    LanT,XiaoY,TangL,et al.Treatment of atrophic acne scarring with fractional micro-plasma radio-frequency in Chinese patients: a prospective study[J].Lasers Surg Med,2018,50(8):844-850.DOI: 10.1002/lsm.22825.
    [20]
    BaroniA,VerolinoP.Plasma radiofrequency ablation for scar treatment[J].J Clin Med,2021,11(1):140.DOI: 10.3390/jcm11010140.
    [21]
    ClarkAK,SaricS,SivamaniRK.Acne scars: how do we grade them?[J].Am J Clin Dermatol,2018,19(2):139-144.DOI: 10.1007/s40257-017-0321-x.
    [22]
    LiB,RenK,YinX,et al.Efficacy and adverse reactions of fractional CO2 laser for atrophic acne scars and related clinical factors: a retrospective study on 121 patients[J].J Cosmet Dermatol,2022,21(5):1989-1997.DOI: 10.1111/jocd.14868.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(3)

    Article Metrics

    Article views (965) PDF downloads(48) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return